Platelet-rich plasma (PRP) · Lesson 7 of 25 · 3 min

How to read PRP research: lab studies, animal models and clinical trials

PRP evidence runs from cell studies to animal models to human trials. Each level answers different questions and has its own limits.

Gloved hands placing a sample tube into a centrifuge

Key takeaways.

  • PRP research runs along a continuum from cell studies to animal models to human trials.
  • In vitro studies show mechanisms but cannot capture healing in a living organism.
  • Animal models add tissue-level and safety data, but healing biology differs between species.
  • Uncontrolled case series generate hypotheses and cannot prove causation.
  • Randomized controlled trials give the highest level of evidence for a treatment effect.
  • Check who was studied and how the PRP was prepared before applying a result.

In vitro studies

In vitro means in the laboratory, outside a living organism. These studies expose cells such as fibroblasts, chondrocytes or stem cells to PRP under controlled conditions. They allow precise study of cellular responses and molecular mechanisms.

Their limit is the same thing that makes them useful. A controlled dish cannot reproduce the complex environment of living tissue, so these studies cannot predict clinical responses on their own.

Animal models

Animal studies bridge the gap between the laboratory and human trials. They let researchers follow healing over time in intact tissue and assess biomechanical outcomes and possible adverse effects. Small animals such as rats and rabbits often provide the first evidence in a living system.

The main limitation is that healing biology differs between species. A result in an animal model is a reason to study something in humans, not evidence that it applies to them.

Clinical studies

Case series and observational studies often give the first clinical picture. They are uncontrolled, so improvements might reflect natural healing, placebo effects or other treatments. They are useful for generating hypotheses and documenting real-world use.

Randomized controlled trials (RCTs) assign participants at random to PRP or a control. This minimizes bias and allows direct comparison. The CONSORT 2025 statement provides a 30-item checklist for reporting a randomized trial.

Questions to ask of any PRP trial

Look at who was enrolled. Many trials exclude people with diabetes, obesity, a smoking history or multiple comorbidities, yet these patients are common in practice. A result in young athletes with acute injuries may not apply to older patients with degenerative conditions.

Look at how the PRP was prepared. Products differ between studies, so two PRP trials may not have tested the same thing.

Educational content for healthcare professionals. Not a treatment recommendation. PRP applications are considered off-label.

Platelet-rich plasma (PRP): 0 of 25 lessons finished

All lessons

This guide covers the what and the why.

The how is taught live. The webinar and live training go deeper on:

  • Critical appraisal of key PRP trials
  • Evidence by indication
  • Translating trial findings to real patients
  • Outcome measures used in PRP research

Common questions.

What is the highest level of evidence for PRP?
Randomized controlled trials provide the highest level of evidence for a treatment effect. Even so, they need careful reading for participant selection and preparation method.
Can lab or animal studies show that PRP works in patients?
No. They provide mechanistic and safety insights, but in vitro systems are simplified and healing biology differs between species.
Why is it hard to compare PRP trials?
Trials often enroll different populations and use different PRP preparations. Results from one setting may not carry over to another.

Sources

  • EQUATOR Network. "CONSORT 2025 Statement: updated guideline for reporting randomised trials." 2025.
  • PMC. "Action of Platelet-Rich Plasma on In Vitro Cellular Bioactivity: More than Platelets." PMC10049396.

Ready for the hands-on detail?

Live on Zoom, Tuesdays at 12:00 PM ET. See how the model works before you commit to anything.